Health Sciences In The Media Fountain Life partners with Global Wellness Institute for the Wellness Moonshot Oct. 20, 2022 Fountain Life will be the 2023 sponsor of the Global Wellness Institute's Wellness Moonshot campaign to create a world free of preventable disease. Club & Resort Business Analgesic use after COVID-19 vaccination does not negatively affect antibody responses Oct. 20, 2022 UArizona Health Sciences research published as a preprint on medRxiv showed no evidence that the use of analgesics following COVID-19 vaccination had a negative effect on antibody responses. News Medical Hidden treasures of University of Arizona Libraries Oct. 19, 2022 The UArizona Health Sciences Library, located in the College of Medicine – Tucson, is among the many libraries to frequent on campus. Arizona Daily Wildcat Melatonin can be a nightmare if used incorrectly, experts say Oct. 19, 2022 Melatonin supplements are designed to mimic the effects of the hormone, boosting its levels within the body to induce sleep. United Press International Certain class of diabetes meds could cut dementia risk Oct. 19, 2022 Xin Tang, a student in the Mel and Enid Zuckerman College of Public Health, is the first author on a paper that found that in patients with Type 2 diabetes, thiazolidinedione monotherapy is associated with reduced dementia risk and sulfonylurea monotherapy is associated with an increased risk compared with metformin monotherapy. HealthDay Drug meant to prevent premature births should be removed from market, FDA panel says Oct. 19, 2022 A federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work. Los Angeles Times UArizona Arthritis Center awarded $3.4M to study rapid knee deterioration Oct. 18, 2022 Researchers at the UArizona Arthritis Center are undertaking a study that seeks to identify determinants of rapid knee deterioration thanks to a $3.4 million grant from the National Institutes of Health. KVOA-TV (Tucson, AZ) Vonoprazan promising for erosive esophagitis Oct. 18, 2022 The oral potassium-competitive acid blocker vonoprazan was noninferior and superior to the proton pump inhibitor lansoprazole for erosive esophagitis, according to results of the phase 3 trial. Medscape The role of biomarker testing in ovarian cancer Oct. 17, 2022 The identification of predictive and prognostic biomarkers has become increasingly important in the diagnosis and treatment of ovarian cancers, especially as newer biomarkers emerge. Targeted Oncology Free training in Arizona to know how to deal with an opioid overdose Oct. 17, 2022 As part of the fight against the opioid crisis, the UArizona Center for Rural Health offers free training on how to apply naloxone and what to do in an emergency. Univision (Phoenix, AZ) Pagination « First First page ‹ Previous Previous page … 141 142 143 144 145 146 147 148 149 … Next › Next page Last » Last page
Fountain Life partners with Global Wellness Institute for the Wellness Moonshot Oct. 20, 2022 Fountain Life will be the 2023 sponsor of the Global Wellness Institute's Wellness Moonshot campaign to create a world free of preventable disease. Club & Resort Business
Analgesic use after COVID-19 vaccination does not negatively affect antibody responses Oct. 20, 2022 UArizona Health Sciences research published as a preprint on medRxiv showed no evidence that the use of analgesics following COVID-19 vaccination had a negative effect on antibody responses. News Medical
Hidden treasures of University of Arizona Libraries Oct. 19, 2022 The UArizona Health Sciences Library, located in the College of Medicine – Tucson, is among the many libraries to frequent on campus. Arizona Daily Wildcat
Melatonin can be a nightmare if used incorrectly, experts say Oct. 19, 2022 Melatonin supplements are designed to mimic the effects of the hormone, boosting its levels within the body to induce sleep. United Press International
Certain class of diabetes meds could cut dementia risk Oct. 19, 2022 Xin Tang, a student in the Mel and Enid Zuckerman College of Public Health, is the first author on a paper that found that in patients with Type 2 diabetes, thiazolidinedione monotherapy is associated with reduced dementia risk and sulfonylurea monotherapy is associated with an increased risk compared with metformin monotherapy. HealthDay
Drug meant to prevent premature births should be removed from market, FDA panel says Oct. 19, 2022 A federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work. Los Angeles Times
UArizona Arthritis Center awarded $3.4M to study rapid knee deterioration Oct. 18, 2022 Researchers at the UArizona Arthritis Center are undertaking a study that seeks to identify determinants of rapid knee deterioration thanks to a $3.4 million grant from the National Institutes of Health. KVOA-TV (Tucson, AZ)
Vonoprazan promising for erosive esophagitis Oct. 18, 2022 The oral potassium-competitive acid blocker vonoprazan was noninferior and superior to the proton pump inhibitor lansoprazole for erosive esophagitis, according to results of the phase 3 trial. Medscape
The role of biomarker testing in ovarian cancer Oct. 17, 2022 The identification of predictive and prognostic biomarkers has become increasingly important in the diagnosis and treatment of ovarian cancers, especially as newer biomarkers emerge. Targeted Oncology
Free training in Arizona to know how to deal with an opioid overdose Oct. 17, 2022 As part of the fight against the opioid crisis, the UArizona Center for Rural Health offers free training on how to apply naloxone and what to do in an emergency. Univision (Phoenix, AZ)